Association of autonomic dysfunction and clozapine: Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Antipsychotic medications cause a wide range of adverse effects and have been associated with sudden death in psychiatric patients. Aims: To supply power spectral analysis of heart rate variability as a tool to examine the arrythmogenic effects of neuroleptics. Method: Heart rate analysis was carried out in patients with schizophrenia on standard doses of neuroleptic monotherapy − 21 were on clozapine, 18 on haloperidol and 17 on olanzapine – and in 53 healthy subjects. Results: Patients with schizophrenia on clozapine had significantly higher heart rate, lower heart rate variability and lower high-frequency and higher low-frequency components compared with patients on haloperidol or olanzapine and matched control subjects. Prolonged QTc intervals were more common in patients than controls. Conclusions: Patients treated with neuroleptic medications, especially clozapine, showed autonomic dysregulation and cardiac repolarisation changes. Physicians should be aware of this adverse reaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., & Schwartz, P. J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014868 · Cited by 15,289
Akselrod, S., Gordon, D., Ubel, F. A., Shannon, D. C., Berger, A. C., & Cohen, R. J. (1981) · Science · doi:10.1126/science.6166045 · Cited by 5,079
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
Reilly, J., Ayis, S., Ferrier, I., Jones, S., & Thomas, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02035-3 · Cited by 602
Sudden death in psychiatric patients
Ruschena, D., Mullen, P. E., Burgess, P., Cordner, S., Barry-Walsh, J., Drummer, O., Palmer, S., Browne, C., & Wallace, C. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.4.331 · Cited by 217
Sudden unexplained death in psychiatric in-patients
Appleby, L., Thomas, S., Ferrier, N., Lewis, G., Shaw, J., & Amos, T. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.5.405 · Cited by 87
Cited by
Laborde, S., Mosley, E., & Thayer, J. F. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.00213 · Cited by 2,336
“…and Saint, 2011) • Habitual levels of alcohol consumption (Quintana et al., 2013a,b) • Weight, height and waist-to-hip ratio (Yi et al., 2013) • Cardioactive medication, such as antidepressant (Kemp et al., 2010), antipsychotic (Cohen et al., 2001) or antihypertensive (Schroeder et al., 2003).”
BackgroundThe 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., Himelhoch, S., Fang, B., Peterson, E., Aquino, P. R., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp116 · Cited by 907
Mandelli, L., Petrelli, C., & Serretti, A. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.04.007 · Cited by 549
Alvares, G. A., Quintana, D. S., Hickie, I. B., & Guastella, A. J. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140217 · Cited by 503
Considerations in the assessment of heart rate variability in biobehavioral research
Quintana, D. S., & Heathers, J. A. J. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00805 · Cited by 395
Clamor, A., Lincoln, T. M., Thayer, J. F., & Koenig, J. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.160762 · Cited by 167
Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system
Leung, J. Y. T., Barr, A. M., Procyshyn, R. M., Honer, W. G., & Pang, C. C. Y. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.04.003 · Cited by 163
Jung, W., Jang, K.-I., & Lee, S.-H. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.4.459 · Cited by 81
Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
Yuen, J. W. Y., Kim, D. D., Procyshyn, R. M., White, R. F., Honer, W. G., & Barr, A. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00203 · Cited by 79
Reduced heart rate variability in schizophrenia and bipolar disorder compared to healthy controls
Quintana, D. S., Westlye, L. T., Kaufmann, T., Rustan, Ø. G., Brandt, C. L., Haatveit, B., Steen, N. E., & Andreassen, O. A. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12498 · Cited by 73
Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia
Iwamoto, Y., Kawanishi, C., Kishida, I., Furuno, T., Fujibayashi, M., Ishii, C., Ishii, N., Moritani, T., Taguri, M., & Hirayasu, Y. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-199 · Cited by 56
“imbalance between sympathetic and parasympathetic nerve activity [18,19] and that other antipsychotics drugs, such as haloperidol, which are relatively free of significant effects on neurotransmitter receptors except dopamine receptors, have no significant effect on ANS activity [19,38].”
BackgroundResultChanges in heart rate dynamics of patients with schizophrenia treated with risperidone
Chang, J. S., Yoo, C. S., Yi, S. H., Hong, K. H., Lee, Y.-S., Oh, H. S., Jung, D. C., Kim, Y. S., & Ahn, Y. M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.017 · Cited by 43
Chung, M.-S., Yang, A. C., Lin, Y.-C., Lin, C.-N., Chang, F.-R., Shen, S.-H., Ouyang, W.-C., Loh, E.-W., & Chiu, H.-J. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.07.034 · Cited by 34
Cardiac autonomic dysregulation in acute schizophrenia
Chang, H.-A., Chang, C.-C., Tzeng, N.-S., Kuo, T. B. J., Lu, R.-B., & Huang, S.-Y. (2013) · Acta Neuropsychiatrica · doi:10.1111/acn.12014 · Cited by 30
“Our findings also reinforce prior reports urging caution in the prescription of clozapine in schizophrenic patients with cardiovascular dysfunction because its potent anticholinergic properties can lead to reduced vagal tone and HRV (13,31,51).”
ResultEffects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia
Hattori, S., Kishida, I., Suda, A., Miyauchi, M., Shiraishi, Y., Fujibayashi, M., Tsujita, N., Ishii, C., Ishii, N., Moritani, T., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.004 · Cited by 29
Heart Rate Variability and Metabolic Syndrome in Hospitalized Patients with Schizophrenia
Lee, K., Park, J., Choi, J., & Park, C. G. (2011) · Journal of Korean Academy of Nursing · doi:10.4040/jkan.2011.41.6.788 · Cited by 15
Suda, A., Hattori, S., Kishida, I., Miyauchi, M., Shiraishi, Y., Fujibayashi, M., Tsujita, N., Ishii, C., Ishii, N., Moritani, T., et al. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s173617 · Cited by 5
Metadata
- Authors
- Cohen, H., Loewenthal, U., Matar, M., & Kotler, M.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2001-08
- Volume
- 179
- Issue
- 2
- Pages
- 167-171
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W1955497802
- Cited by
- 134
- References
- 5
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.